BBVA USA Bancshares’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $1.78M | Buy |
6,155
+244
| +4% | +$70.7K | 0.08% | 222 |
|
|
2020
Q4 | $1.48M | Sell |
5,911
-414
| -7% | -$103K | 0.08% | 236 |
|
|
2020
Q3 | $1.43M | Sell |
6,325
-297
| -4% | -$67.2K | 0.08% | 212 |
|
|
2020
Q2 | $1.15M | Buy |
6,622
+272
| +4% | +$47.4K | 0.07% | 234 |
|
|
2020
Q1 | $802K | Buy |
6,350
+696
| +12% | +$87.9K | 0.06% | 255 |
|
|
2019
Q4 | $863K | Buy |
+5,654
| New | +$863K | 0.05% | 289 |
|
|
2019
Q3 | – | Sell |
-5,692
| Closed | -$808K | – | 406 |
|
|
2019
Q2 | $808K | Buy |
5,692
+146
| +3% | +$20.7K | 0.05% | 291 |
|
|
2019
Q1 | $805K | Buy |
5,546
+166
| +3% | +$24.1K | 0.05% | 284 |
|
|
2018
Q4 | $609K | Sell |
5,380
-359
| -6% | -$40.6K | 0.04% | 307 |
|
|
2018
Q3 | $772K | Sell |
5,739
-38
| -0.7% | -$5.11K | 0.05% | 308 |
|
|
2018
Q2 | $648K | Buy |
5,777
+121
| +2% | +$13.6K | 0.04% | 320 |
|
|
2018
Q1 | $603K | Buy |
5,656
+118
| +2% | +$12.6K | 0.04% | 341 |
|
|
2017
Q4 | $607K | Sell |
5,538
-572
| -9% | -$62.7K | 0.04% | 341 |
|
|
2017
Q3 | $660K | Buy |
6,110
+106
| +2% | +$11.5K | 0.04% | 327 |
|
|
2017
Q2 | $607K | Buy |
6,004
+50
| +0.8% | +$5.06K | 0.04% | 339 |
|
|
2017
Q1 | $536K | Buy |
5,954
+285
| +5% | +$25.7K | 0.04% | 353 |
|
|
2016
Q4 | $431K | Buy |
5,669
+163
| +3% | +$12.4K | 0.03% | 385 |
|
|
2016
Q3 | $459K | Buy |
5,506
+2,025
| +58% | +$169K | 0.03% | 371 |
|
|
2016
Q2 | $287K | Buy |
+3,481
| New | +$287K | 0.02% | 445 |
|